IL1B and breast carcinoma: The present results suggest that breast cancer survivors with PD have worse cognitive functioning based on a cognitive screening test and lower quality of life than the PD group, and significantly higher levels of IL‐1β, TNF‐α, and IL‐4, compared to the patients with NPD.